—Տ°–òÜŠw‹³Žº

Department of Clinical Pharmaceutics

ƒCƒ[ƒW


§981-8558
‹{éŒ§å‘äŽsÂ—t‹æ¬¼“‡4’š–Ú4-1
“Œ–kˆã‰È–ò‰È‘åŠw–òŠw•”@—Տ°–òÜŠw‹³Žº
TEL 022-727-0210
i“àü 4410j
FAX 022-727-0149

ƒƒ“ƒo[

 

‹³@Žö

’†‘º@m@

‹³@Žö

•@‹³

•@Žè

 

”ŽŽm‚P”N

‘ºˆäƒ†ƒŠŽq

—é–؁@—T”V

”ª–؁@•ü”ü

 

‚‹´@«“T

6@”N

ˆÉ“¡@—´“ñC‰ª•”@Žj“ށCŒüˆä@—BC¬¼@x—ºC¬›@“¹—mC¯“à@ŠóC¼”ö@‹Ü“ށC

™‘º@ç•äC´…@“NCÎ“c@—m‰îC‘]‰ä@‰À‘¾û¶C‘¾“c@çŒb”üC’–ŒÒ@–ƒ—œˆ¤

5@”N

ˆ¢•”@«‘¾C‰““¡@—D–çC‚–؁@–ƒ—FC²“¡@‚«‚ç‚çC²“¡@ C²“¡@—I‘¾CŽO‰Y@]仍C

¬¼@‚Ђ©‚èC¬“c@‰À“ށCÔâ@‰p‹MC“n•Ó@k•ãC“n糁@–ƒ—¢]C–Ø‘º@«ãY

 

Œ¤‹†“à—e


@–òÜŽt‚ɂ͈ã—ÃŒ»ê‚É‹N‚±‚é—lX‚È–â‘è“_‚ð”­Œ©‚µA‚»‚ê‚ð‰ðŒˆ‚µ‚½‚è–¢‘R‚É–h‚¢‚¾‚è‚·‚é”\—Í‚ª‹‚ß‚ç‚ê‚Ü‚·B“–‹³Žº‚ł͈ã—ÃŒ»ê‚Å–â‘è‚Æ‚È‚Á‚Ä‚¢‚é—lX‚ȃe[ƒ}‚ðŽæ‚èã‚°Aˆã—ÃŽ{Ý‚ƘAŒg‚µ‚È‚ª‚猤‹†‚ði‚ß‚Ä‚¢‚Ü‚·B

1. ˆã–ò•iî•ñƒf[ƒ^‚̍ČŸ“¢‚Æ‚»‚ê‚ÉŠî‚­—Տ°‚Ŗ𗧂ƒf[ƒ^ƒx[ƒX‚̍\’z
2. ˆê”Ê—pˆã–ò•i‚⌒NH•i‚Ì“K³Žg—p‚ÉŠÖ‚·‚é’²¸Œ¤‹†
3. –òÜŽt‹Æ–±‚Æ–òŠw‹³ˆç‚ÉŠÖ˜A‚·‚é’²¸Œ¤‹†
4. –ò•¨—Ö@‚Ì–òŠw“I•]‰¿Žw•W‚ÉŠÖ‚·‚錤‹†
5. Š³ŽÒî•ñ‚ð—p‚¢‚½–òŒø‚¨‚æ‚Ñ•›ì—p‚Ì•]‰¿
6. »Ü‚̈À’萫ŽŽŒ±

@‚Ü‚½A‹³ˆç–Ê‚Å‚ÌŽå‚ÈŠˆ“®‚Æ‚µ‚ẮA—Տ°–òÜŽt‚É•K—v‚È’mŽ¯E‹Zp‚Ì‹³Žö‚ª‚ ‚è‚Ü‚·Bu‹`‚¨‚æ‚їՏ°–òÜŠwŽÀKƒZƒ“ƒ^[‚Å‚ÌŽÀ–±ŽÀKŽ–‘O‹³ˆç‚ð’Ê‚µ‚āAŠw¶‚̃XƒLƒ‹ƒAƒbƒv‚ðƒTƒ|[ƒg‚µ‚Ä‚¢‚Ü‚·B
@“–‹³Žº‚͈ã—ÃŒ»ê‚ÌŽíX‚Ì–â‘è‚ð‰ðŒˆ‚µAŠ³ŽÒ–ž‘«“x‚ðŒüã‚³‚¹‚邽‚ß‚Ì–òÜŽt‹Æ–±‚ðŽx‚¦Aƒtƒ@[ƒ}ƒVƒ…[ƒeƒBƒJƒ‹ƒPƒA‚ɍvŒ£‚µ‚Ä‚¢‚«‚Ü‚·B

 

”­•\˜_•¶i2000`j


”­•\˜_•¶
(2015)
Effect of plantar subcutaneous administration of bergamot essential oil and linalool on formalin-induced nociceptive behavior in mice.

Katsuyama S., Otowa A., Kamio S., Sato K., Yagi T., Kishikawa Y., Komatsu T., Bagetta G., Sakurada T., Nakamura H.

Biomed. Res., 36: 47-54 (2015).


 (2014)
–«•s–°Ç‚ɑ΂·‚郉ƒƒ‹ƒeƒIƒ“‚ƃ]ƒ‹ƒsƒfƒ€‚Ì—LŒø«EˆÀ‘S«‚ÉŠÖ‚·‚郁ƒ^ƒAƒiƒŠƒVƒX
ŠÝìK¶, “c‘º@Ê, ”ª–Ø•ü”ü, ŸŽR@‘s, ’†‘º@m.
ˆã–ò•i‘ŠŒÝì—pŒ¤‹†, 37 : 160-167i2014j.

Antinociceptive effects of the serotonin and noradrenaline reuptake inhibitors milnacipran and duloxetine on vincristine-induced neuropathic pain model in mice.

Katsuyama S., Aso H., Otowa A., Yagi T., Kishikawa Y., Komatsu T., Sakurada T., Nakamura H.

ISRN Pain, 2014: Article ID 915464, 7 pages (2014)

 (2013)

‹~‹}ˆã—ÂƖòŠw‹³ˆç‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸‚̉ðÍ.

”ª–Ø•ü”üC”©ŽRŽj˜N, CŸŽR@‘sCŠÝìK¶C’†‘º@m.

“ú•a–òŽ, 49 : 1197-1201i2013j.


Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model.

Katsuyama S., Sato K., Yagi T., Kishikawa Y., Nakamura H.

Biomed. Res., 34: 105-111 (2013).

Involvement of peripheral cannabinoid and opioid receptors in
ƒÀ-caryophyllene-induced antinociception.
Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T, Sakurada S.
Eur. J. Pain, 17: 664-675 (2013)

 (2012)

Local Peripheral Effects of ƒÀ-Caryophyllene through CB2 Receptors in Neuropathic Pain in Mice

Kuwahata H., Katsuyama S., Komatsu T., Nakamura H., Corasaniti M. T., Bagetta G., Sakurada S., Sakurada T., Takahama K.

Pharmacology & Pharmacy, 3: 397-403 (2012).

Intraplantar Injection of Linalool Reduces Paclitaxel-Induced Acute Pain in Mice.

Katsuyama S., Kuwahata H., Yagi T., Kishikawa Y., Komatsu T., Sakurada T., Nakamura H.

Biomed. Res., 33: 175-181 (2012).

ˆã–ò•i‚̗Տ°ŒŸ¸’l–WŠQ‚ÉŠÖ‚·‚éî•ñ‚Ì’²¸.
’†‘º@mC“c‘ã–ƒ”üC²“¡O”üC‚‹´@Œ÷C”ª–Ø•ü”üCŸŽR@‘sCŠÝìK¶C —R—lj·éC“y‰®ß•v
ˆã–ò•iî•ñŠw, 13: 199-204 (2012)


 (2011)
Comparative Clinical Evaluation of Efficiency and Safety between Original Drug and Generic Products (II).
Kishikawa Y., Iwasaki T., Ito M., Ishikura K., Ikeda K., Sato K., Kon-no Y., Yagi T., Katsuyama S., Shindo M., Minakawa D., Nakamura H., Mizugaki M.
Jpn. J. Drug Inform., 13: 86-94 (2011).

‚ª‚ñ‰»Šw—Ö@‚É”º‚¤––½_ŒoáŠQ‚ÉŠÖ‚·‚éŽÀ‘Ô’²¸
ŸŽR@‘sC²X–Ø”üDC”ª–Ø•ü”üCŠÝìK¶C’†‘º@m
“ú•a–òŽ, 47: 207-210 (2011)

(2010)
Comparative Clinical Evaluation of Efficiency and Safety between Original Drug and Generic Products (I).
Yukinaga Kishikawa, Tomomi Iwasaki, Megumi Ito, Kazuki Ishikura, Kaoko Ikeda,@Keigo Sato, Yumiko Kon-no, Hitoshi Nakamura, Michinao Mizugaki
Jpn. J. Generic Medicines, 3, 127-135(2010)


‘à“™
(2015)
t‹@”\‚̈«‰»‚ð–h‚®‚½‚ß‚Ì–ò•¨—Ö@ CKD‚ÌŽ¡—Öò‚Æ‚µ‚āA‚È‚ºRAS‘jŠQ–ò‚ª•K—v‚È‚Ì‚©?

ŠÝìK¶
’²Ü‚Əî•ñ, 21, 1298-1306@(2015)

(2014)
ƒx[ƒ^ƒJƒŠƒIƒtƒBƒŒƒ“‚̃}ƒEƒXŒãŽˆ‘«çG“à”牺“Š—^‚É‚æ‚éƒJƒvƒTƒCƒVƒ“—U”­«NŠQŽhŒƒ‚¨‚æ‚ѐ_ŒoáŠQ«áu’ɂɑ΂·‚é—}§Œø‰Ê

ŸŽR@‘s, ¬¼¶–¾, ’†‘º@m, ŸN“c@Ži

AROMA RESEARCH, 15, 133-139@(2014)

‘åŠw”­ƒAƒƒ}ƒeƒ‰ƒs[‚̍¡F‘åŠw‚É‚¨‚¯‚éƒAƒƒ}ƒeƒ‰ƒs[‚ÌŽæ‚è‘g‚Ý‚Æ‚»‚ÌŒ»ó

ŸŽR@‘s, ’†‘º@m, ¬¼¶–¾, ŸN“c@Ži

aromatopia, 123, 52-53@(2014)

 (2012)
R‚ª‚ñÜ‚É‚æ‚é––½_ŒoáŠQ‚Æ‚»‚̑Ήžô‚ɂ‚¢‚Ä
ŸŽR@‘s, ”ª–Ø•ü”ü, ŠÝìK¶, ’†‘º@m
–òŽ–V•ñ, 2727,  352-356@(2012)


Šw‰ï”­•\

(2018)

•ª•ïŽ†‚̈Ⴂ‚É‚æ‚é’²Ü—pƒpƒ“ƒrƒ^ƒ“––’†‚Ì—tŽ_ŠÜ—ʒቺ‚̍·ˆÙ

—é–Ø—T”V, ˆÀ•””ü—¢, ‹{‰Y½Ž¡, ’–‰ª‹žŽq, ’†‘º’B–ç, ”ª–Ø•ü”ü, ‰äÈ‹±s,—é–؏í‹`, ‘ºˆäƒ†ƒŠŽq, ûü‘ºç’ÃŽq, ’†‘º m

“ú–{–òŠw‰ï‘æ138”N‰ï, ‹à‘ò, 2018”N3ŒŽ

 

(2017)

‘å‹K–Í‚ÈŽs”̌㒲¸ƒf[ƒ^‚ÉŠî‚­CahR–ò‚̍~ˆ³‘¬“xstabilization time‚ÌŽZo

–ì“cŽÑ–獁C²“¡—ύLC—é–Ø—T”VC”ª–Ø•ü”üC‘ºã”C®C–ÚŽžOmC‘ºˆäƒ†ƒŠŽqC’†‘º@m

‘æ27‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïCç—tC2017”N11ŒŽ

 

JADER‚ð—p‚¢‚½•›ì—pƒvƒƒtƒ@ƒCƒ‹‰ðÍ‚Ì—L—p«

’†‘º@m, ŽR‘º‘ñŠC, —é–Ø—T”V, ‹e’r‘å•ã, ”ª–Ø•ü”ü, ”–ˆäŒ’‰î, ŠÝìK¶, “n粑PÆ

“ú–{–òŠw‰ï‘æ137”N‰ï, å‘ä, 2017”N3ŒŽ.

 

ˆã–ò•iŠÖ˜AƒXƒ}[ƒgƒtƒHƒ“ƒAƒvƒŠ‚ÌŒ»ó’²¸

”ª–Ø•ü”ü, ‹î—эK‘¾˜Y, —é–Ø—T”V, ”–ˆäŒ’‰î, ŠÝìK¶, “n粑PÆ, ’†‘º@m

“ú–{–òŠw‰ï‘æ137”N‰ï, å‘ä, 2017”N3ŒŽ.

 

ŠeŽí•ÛŠÇðŒ‰º‚É‚¨‚¯‚镪•ïŒã’²Ü—pƒpƒ“ƒrƒ^ƒ“––‚ÌŠOŠÏ•Ï‰»‚Æ—tŽ_ŠÜ—Ê‚ÌŒŸ“¢

—é–Ø—T”V, ‹{‰Y½Ž¡, ’–‰ª‹žŽq, ’†‘º’B–ç, ‘ºŽR•ü”ü, ”ª–Ø•ü”ü, ŠÝìK¶, ‰äÈ‘׍s, —é–؏í‹`, ûü‘ºçŽõŽq, —é–ØŠ²Žq, ’†‘º@m

“ú–{–òŠw‰ï‘æ137”N‰ï, å‘ä, 2017”N3ŒŽ.

 

ƒjƒRƒyƒŠƒbƒN®• –Œ“§Í‰t’†‚̃Zƒtƒ@ƒ]ƒŠƒ“‚¨‚æ‚уZƒtƒ^ƒWƒWƒ€‚̈À’萫‚ÌŒŸ“¢

‰F–ì@‹Ä, —é–Ø—T”V, H“¡Ÿ, ‹e’r‘å•ã, •½ìŠ°”V, ”ª–Ø•ü”ü, ”–ˆäŒ’‰î, ‰äÈ‘׍s, ’†‘º@m, —é–؏í‹`, X@Œ’•¶, “n糑PÆ

“ú–{–òŠw‰ï‘æ137”N‰ï, å‘ä, 2017”N3ŒŽ.


(2016)

‰@“à»Ü‚Ì•iŽ¿ŽŽŒ±‚ÌŽÀ‘H           

—é–Ø—T”V

‘æ15‰ñˆã—ÖòŠwŽáŽèŒ¤‹†ŽÒƒZƒ~ƒi[u—Տ°‚ɍª·‚µ‚½–òŠwŒ¤‹†v, å‘ä, 2016”N10ŒŽ

 

“ú–{ƒAƒ“ƒ`Eƒh[ƒsƒ“ƒO‹@\ŒöŠJŽ‘—¿‚ðŠî‚É‚µ‚½ƒh[ƒsƒ“ƒO–hŽ~‹K‘¥ˆá”½‚ÌŒ»ó’²¸

”–ˆäŒ’‰î, ¬–ì‘P‹P, ”ª–Ø•ü”ü, —é–Ø—T”V, ŠÝìK¶, “n粑PÆ, ’†‘ºm

‘æ48‰ñ“ú–{–òÜŽt‰ïŠwp‘å‰ï, –¼ŒÃ‰®, 2016”N10ŒŽ

 

Beclomethasone dipropionate ’°—n«ƒJƒvƒZƒ‹‚Ì’²»‚Æ•iŽ¿‚ÌŒŸ“¢

“à“c@Œh, —é–Ø—T”V, —с@Ž„, “艪”ü, ’–‰ª‹žŽq, ”ª–Ø•ü”ü, ŠÝìK¶, ‰äÈ‹±s, ’†‘º@m, —é–؏í‹`, ‚‘ºç’ÃŽq, —é–ØŠ²Žq

‘æ26‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï, ‹ž“s, 2016”N9ŒŽ.

 

(2015)

CKD Š³ŽÒ‚ɑ΂·‚é RAS ‘jŠQ–ò•¹—p‚É‚æ‚é”A’`”’”rŸ•—}§Œø‰Ê‚ÉŠÖ‚·‚铝ŒvŠw“IŒŸ“¢

‹«“c—z‰î, ŠÝìK¶, ”ª–Ø•ü”ü, —é–Ø—T”V, ’†‘º@m

‹{é–òÜŽtŠwpƒtƒH[ƒ‰ƒ€ 2015, å‘ä, 2015”N11ŒŽ

Restless Legs Syndrome Ž¡—Öò‚Ì—LŒø«EˆÀ‘S«‚ÉŠÖ‚·‚铝ŒvŠw“IŒŸ“¢

™ŽR”üŽ÷, ŠÝìK¶, ”ª–Ø•ü”ü, —é–Ø—T”V, ’†‘º@m

‹{é–òÜŽtŠwpƒtƒH[ƒ‰ƒ€ 2015, å‘ä, 2015”N11ŒŽ

“ü‰@Žž‚̐t‹@”\‚ÆŽŽQ‚µ‚½ƒvƒŒƒKƒoƒŠƒ“‚Ì•ž—p—ʂɂ‚¢‚Ä

”–ˆäŒ’‰îA‹e’r‘å•ãA“y‰®ß•v

‘æ9‰ñ“ú–{t‘Ÿ•a–ò•¨—Ö@Šw‰ïŠwpW‰ï, å‘ä, 2015”N10ŒŽ

‘åŠw‰@1”N¶‚̗Տ°Œ¤C‚©‚猩‚½‰Â”\«

“y‰®ß•v

‘æ1‰ñ“ú–{ˆã–ò•iˆÀ‘S«Šw‰ïŠwp‘å‰ï, •ŸŽR, 2015”N7ŒŽ

ˆê”Ê—pˆã–ò•i‚̏î•ñ’ñ‹Ÿ‚ÉŠÖ‚·‚é–òÜŽtE“o˜^”Ì”„ŽÒ‚ւ̃Aƒ“ƒP[ƒg’²¸

”ª–Ø•ü”üAŒF’J–¢—ˆAŸŽR@‘sAŠÝìK¶A’†‘º@m

“ú–{–òŠw‰ï‘æ135”N‰ï, _ŒË, 2015”N3ŒŽ

“Œ–k–ò‰È‘åŠw‚É‚¨‚¯‚é‘åŠw‰@¶‚̗Տ°–òŠwŒ¤C‚ɂ‚¢‚Ä

”–ˆä Œ’‰îA—é–Ø mŽuA‘å‰ÍŒ´ —YˆêA“y‰®ß•vA‘å–ì ŒM

“ú–{–òŠw‰ï‘æ135”N‰ï, _ŒË, 2015”N3ŒŽ

SGLT2 ‘jŠQ–ò‚Ì—LŒø«EˆÀ‘S«‚Ì“ŒvŠw“IŒŸ“¢

ŠÝìK¶A–Ø‘ºVŒÞA”ª–Ø•ü”üAŸŽR@‘sA’†‘º@m

‘æ145 ‰ñ‹{éŒ§•a‰@–òÜŽt‰ïŠwpŒ¤‹†”­•\‰ï, å‘ä, 2015”N3ŒŽ

 

(2014)

“Œ‹ž‘‘̂ł̃Aƒ“ƒP[ƒg’²¸‚©‚瓾‚ç‚ꂽƒh[ƒsƒ“ƒO–hŽ~‚ÉŠÖ‚·‚é‘IŽè‚¨‚æ‚Ñ—ˆêŽÒ‚̈ӎ¯

”–ˆäŒ’‰îA‹ß“¡“ÞŽqA¬—Ñ•S‘ãA£’J‰ësAŒIŽR‰qA¬’|ŒcŽqA‚‹´³•vA¼Œ´”£A“y‰®ß•vA’†‘ºm

‘æ47‰ñ“ú–{–òÜŽt‰ïŠwp‘å‰ï, ŽRŒ`, 2014”N10ŒŽ

 

ƒÀ-ƒJƒŠƒIƒtƒBƒŒƒ“‚̃}ƒEƒXŒãŽˆ‘«Õ“à“Š—^‚É‚æ‚éƒJƒvƒTƒCƒVƒ“—U”­«NŠQŽhŒƒ‚ɑ΂·‚é—}§ì—p‚̍s“®–ò—Šw“IŒŸ“¢

ŸŽR@‘sA¬¼¶–¾A’†‘º@mAŸN“c@”EAŸN“c@Ži

‘æ65‰ñ“ú–{–ò—Šw‰ï–k•”‰ï, •Ÿ“‡, 2014”N9ŒŽ

 

Lavender oil ‹ÇŠ“Š—^‚É‚æ‚éRNŠQì—p‚ÌŒŸ“¢

—é–Ø’qŒbAŸŽR@‘sA‰¹‰H@—ºAŽR“cç—¢A”ª–Ø•ü”üAŠÝìK¶A¬¼¶–¾AŸN“c@ŽiA’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2014/‘æ22‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, “Œ‹ž, 2014”N6ŒŽ

 

R‚¤‚–ò‚É‚æ‚éƒIƒLƒTƒŠƒvƒ‰ƒ`ƒ“—U”­«––½_ŒoáŠQ—}§Œø‰Ê‚ÌŒŸ“¢

ŽR“cç—¢AŸŽR@‘sA—é–Ø’qŒbA”ª–Ø•ü”üAŠÝìK¶A’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2014/‘æ22‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, “Œ‹ž, 2014”N6ŒŽ

 

ƒAƒƒ}ƒeƒ‰ƒs[¸–û‹ÇŠ“Š—^‚É‚æ‚éƒpƒNƒŠƒ^ƒLƒZƒ‹—U”­«––½_ŒoáŠQ«áu’É—}§Œø‰Ê‚ÌŒŸ“¢

‰¹‰H@—ºAŸŽR@‘sA”ª–Ø•ü”üAŠÝìK¶A¬¼¶–¾AŸN“c@ŽiA’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2014/‘æ22‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, “Œ‹ž, 2014”N6ŒŽ

 

ˆã–ò•i‚̗Տ°ŒŸ¸–WŠQ‚ÉŠÖ‚·‚錤‹† \”AŽŽŒ±Ž†–@‚É‹y‚Ú‚·ˆã–ò•i‚̉e‹¿\

’†‘º@mA—é–؍ʉāA“ñ•r—Ú”üA”ª–Ø•ü”üAŸŽR@‘sAŠÝìK¶A“y‰®ß•v

“ú–{–òŠw‰ï‘æ134”N‰ï, ŒF–{, 2014”N3ŒŽ

 (2013)
–òŠw¶‚ð‘Ώۂɂµ‚½ê–å–òÜŽtE”F’è–òÜŽt‚ÉŠÖ‚·‚é’²¸

”ª–Ø•ü”üAŸŽR@‘sAŠÝìK¶A’†‘º@m
‘æ52‰ñ“ú–{–òŠw‰ï“Œ–kŽx•”‘å‰ïC å‘äC 2013”N10ŒŽ


tŽ¾Š³Š³ŽÒ‚É‚¨‚¯‚郊ƒtƒB[ƒfƒBƒ“ƒOÇŒóŒQ‚̃ŠƒXƒNˆöŽq‚Ì•ªÍ

ì‘º@˜aG, ŠÝìK¶, ç—t‹MŽu, ˆ¢•”´•F, ”ª–Ø•ü”ü, ŸŽR@‘s, ’†‘º@m

‘æ7‰ñ“ú–{t‘Ÿ•a–ò•¨—Ö@Šw‰ï,@L“‡,@2013”N10ŒŽ

táŠQŠ³ŽÒ‚É‚¨‚¯‚éƒAƒ€ƒzƒeƒŠƒVƒ“BƒŠƒ|ƒ\[ƒ€»Ü‚ÌŽg—p‚ÉŠÖ‚·‚錟“¢

˜a’n@“OAŠÝìK¶Aç—t‹MŽuAˆ¢•”´•FA”ª–Ø•ü”üAŸŽR@‘sA’†‘º@m

‘æ23‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïAå‘äA2013”N9ŒŽ

ƒJƒ‹ƒoƒyƒlƒ€ŒnR‹Û–ò‚ÌŽg—p—ʂƗΔ^‹Û‘ϐ«—¦‚Æ‚ÌŠÖ˜A‚ÉŠÖ‚·‚é’²¸

‘–ìtA‹àŽq‘ì–çAÂ–ؗljxA›Œ´^—ŽqAŽ‡“ŒNŽqAŠÝìK¶AŸŽR@‘sA”ª–Ø•ü”üA’†‘º@m

‘æ23‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïAå‘äA2013”N9ŒŽ

Bergamot essential oil‹y‚ÑŠÜ—L¬•ªLinalool‹ÇŠ“Š—^‚É‚æ‚郂ƒ‹ƒqƒl‚̍RNŠQ•¹—pŒø‰Ê‚ɂ‚¢‚Ä

‰¹‰H@—ºAŸŽR@‘sA–ƒ¶@—zA”ª–Ø•ü”üAŠÝìK¶A¬¼¶–¾AŸN“c@ŽiA’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2013/‘æ21‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, ‹à‘ò, 2013”N7ŒŽ

ƒ~ƒ‹ƒiƒVƒvƒ‰ƒ“‚¨‚æ‚уtƒ‹ƒ{ƒLƒTƒ~ƒ“‚É‚æ‚éƒrƒ“ƒNƒŠƒXƒ`ƒ“—U”­«––½_ŒoáŠQ—}§Œø‰Ê‚ÌŒŸ“¢

–ƒ¶@—zAŸŽR@‘sA‰¹‰H@—ºA”ª–Ø•ü”üAŠÝìK¶A’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2013/‘æ21‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, ‹à‘ò, 2013”N7ŒŽ

ƒ~ƒ‹ƒiƒVƒvƒ‰ƒ“‚¨‚æ‚уtƒ‹ƒ{ƒLƒTƒ~ƒ“‚É‚æ‚éƒpƒNƒŠƒ^ƒLƒZƒ‹—U”­«––½_ŒoáŠQ—}§Œø‰Ê‚ÌŒŸ“¢

ŸŽR@‘sA²“¡ˆê^A”ª–Ø•ü”üAŠÝìK¶A’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2013/‘æ21‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, ‹à‘ò, 2013”N7ŒŽ

Effect of peripherally administered of  bergamot essential oil and linalool on the formalin-induced nociceptive behavior in mice

Soh Katsuyama, Takaaki Komatsu, Tsukasa Sakurada, Hitoshi Nakamura.

International Symposium for Neurosciences 2013, Sendai, February 2013.

 (2012)
MRSA”x‰ŠŠ³ŽÒ‚É‚¨‚¯‚郊ƒlƒ]ƒŠƒh‚ƃoƒ“ƒRƒ}ƒCƒVƒ“‚Ì—LŒø«‚ƈÀ‘S«‚ÉŠÖ‚·‚铝ŒvŠw“IŒŸ“¢

ŒI—с@•à, ŠÝìK¶, ”ª–Ø•ü”ü, ŸŽR@‘s, ’†‘º@m

‘æ22‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïCVŠƒC2012”N10ŒŽ

‹~‹}ˆã—ÂƖòŠw‹³ˆç‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸

”©ŽRŽj˜N, ”ª–Ø•ü”ü, ŸŽR@‘s, ŠÝìK¶, ’†‘º@m

‘æ22‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïCVŠƒC2012”N10ŒŽ

tŽ¾Š³Š³ŽÒ‚ÌŒo’†SÃ–¬‰h—{–@‚É‚¨‚¯‚é“œ•‰‰×ƒŠƒXƒN‚ÌŒŸ“¢

‚¼@Œª, ŠÝìK¶, ç—t‹MŽu, ˆ¢•”´•F, ”ª–Ø•ü”ü, ŸŽR@‘s, ’†‘º@m

‘æ6‰ñ“ú–{t‘Ÿ•a–ò•¨—Ö@Šw‰ï,@ŽD–y,@2012”N9ŒŽ

Bergamot essential oil‹ÇŠ“Š—^‚É‚æ‚éRNŠQì—p

_”öç—¯–¢AŸŽR@‘sA”ª–Ø•ü”üAŠÝìK¶AŒK”g“c“ú—¢AŸN“c@ŽiA’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2012/‘æ20‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, •Ÿ‰ª, 2012”N7ŒŽ

ƒAƒƒ}ƒeƒ‰ƒs[¸–û¬•ªLinalool‹ÇŠ“Š—^‚É‚æ‚éRNŠQì—p

²“¡ˆê^AŸŽR@‘sA”ª–Ø•ü”üAŠÝìK¶A¬¼¶–¾AŸN“c@ŽiA’†‘º@m.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2012/‘æ20‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, •Ÿ‰ª, 2012”N7ŒŽ.

‰–Š˜’n‹æ‚É‚¨‚¯‚钍ŽË—pR‹Û–ò‚ÌŽg—p—ʂƑϐ«‹ÛoŒ»—¦‚ÉŠÖ‚·‚é’²¸
‹àŽq‘ì–çA’†‘º@m
‘æ14‰ñå‰–’n‹æ‰@“àŠ´õÇŒ¤‹†‰ï, ‰–Š˜, 2012”N6ŒŽ

ŒŒ‰t‚ª‚ñ‚É‚¨‚¯‚é”­”M«D’†‹…Œ¸­Ç”­Ç—\‘ªƒXƒRƒA•]‰¿•\‚̍쐬‚Æ‚»‚Ì•]‰¿

‰Á“¡‘å•ãA‹ààV˜a‹MŽqA–ìàVŽõ‹gA²“¡¹ŽqA–쑺@‡AÎàV•¶ÍA”ª–Ø•ü”üAŸŽR@‘sAŠÝìK¶A’†‘º@m

“ú–{–òŠw‰ï‘æ132”N‰ï, ŽD–y, 2012”N3ŒŽ


_Œoˆö«áu’Ƀ‚ƒfƒ‹ƒ}ƒEƒX‚ɑ΂·‚éƒÀ-Caryophyllene‹ÇŠ“Š—^‚É‚æ‚éRƒAƒƒfƒBƒjƒAŒø‰Ê

ŸŽR@‘sA¬¼¶–¾A’·‰ª‚ŽjA’†‘º@mAŸN“c”EAŸN“cŽi

.“ú–{–òŠw‰ï‘æ132”N‰ï, ŽD–y, 2012”N3ŒŽ

 
 (2011)
–«Œ´”­«•s–°‚ɑ΂·‚郉ƒƒ‹ƒeƒIƒ“‚ƃ]ƒ‹ƒsƒfƒ€‚Ì—LŒø«EˆÀ‘S«‚Ì“ŒvŠw“IŒŸ“¢

“c‘º@ÊA ŠÝìK¶A ”ª–Ø•ü”üA ŸŽR@‘sA ’†‘º@m

“ú–{•a‰@–òÜŽt‰ï“Œ–kƒuƒƒbƒN‘æ1‰ñŠwp‘å‰ï,@O‘O,@2011”N11ŒŽ


“§ÍŠ³ŽÒ‚É‚¨‚¯‚é’YŽ_ƒ‰ƒ“ƒ^ƒ“‚Æ’YŽ_ƒJƒ‹ƒVƒEƒ€‚Ì—LŒø«‚ƈÀ‘S«‚ÉŠÖ‚·‚铝Œv“I”äŠr

_@–¢—ˆA ŠÝìK¶A ”ª–Ø•ü”üAŸŽR@‘sA’†‘º@m

“ú–{•a‰@–òÜŽt‰ï“Œ–kƒuƒƒbƒN‘æ1‰ñŠwp‘å‰ï,@O‘O,@2011”N11ŒŽ


‰–Š˜’n‹æ‚É‚¨‚¯‚钍ŽË—pR‹Û–ò‚ÌŽg—pó‹µ‚Æ–òÜ‘ϐ«—¦‚Æ‚ÌŠÖ˜A‚ÉŠÖ‚·‚é’²¸
¬“c“ˆœA”üAÂ–ؗljxA›Œ´^—ŽqAŽ‡“ŒNŽqA‘å–쐳˜aA•š’J@ŠwAŠÝìK¶AŸŽR@‘sA”ª–Ø•ü”üA’†‘º@m
‘æ50‰ñ“ú–{–òŠw‰ï“Œ–kŽx•”‘å‰ïC å‘äC 2011”N10ŒŽ


Œ’NH•i‚̃Gƒrƒfƒ“ƒXƒŒƒxƒ‹‚ÉŠÖ‚·‚é’²¸
‰¡ŽR”¹lA‰©ì“c®ŽjAŠÝìK¶AŸŽR@‘sA”ª–Ø•ü”üA’†‘º@m
‘æ50‰ñ“ú–{–òŠw‰ï“Œ–kŽx•”‘å‰ïC å‘äC 2011”N10ŒŽ


“Œ–k–ò‰È‘åŠwŽÀ–±ŽÀK¶‚Ì“Œ“ú–{‘åkÐŽž‚̏󋵒²¸

”ª–Ø•ü”üCŸŽR@‘sCŠÝìK¶C’†‘º@mC—é–؏í‹`.

ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2011/‘æ19‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€, ˆ®ì, 2011”N7ŒŽ


‚ª‚ñ‰»Šw—Ö@‚É”º‚¤––½_ŒoáŠQ‚ÉŠÖ‚·‚éŽÀ‘Ô’²¸
²X–Ø”üDCŸŽR@‘sC”ª–Ø•ü”üCŠÝì@K¶C’†‘º@m.
“ú–{–òŠw‰ï‘æ131”N‰ï, Ã‰ª, 2011”N3ŒŽ

ŽÀ–±ŽÀK‘OŒã‚Å‚Ì–òŠw¶‚Ì–òÜŽt‚ɑ΂·‚éˆÓŽ¯•Ï‰»
”ª–Ø•ü”üCŸŽR@‘sCŠÝìK¶C’†‘º@mC—é–؏í‹`.
“ú–{–òŠw‰ï‘æ131”N‰ï, Ã‰ª, 2011”N3ŒŽ

(2010)
ŒŒ‰t‚ª‚ñ‚É‚¨‚¯‚é”­”M«D’†‹…Œ¸­ÇƒŠƒXƒNˆöŽq‚ÌŒŸ“¢
‰Á“¡@‘å•ãC–ìàV@Žõ‹gC²“¡@¹ŽqC–쑺@‡CÎàV@•¶ÍC”ª–؁@•ü”üCŸŽR@‘sC ŠÝì@K¶C’†‘º@m
‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï, ç—t, 2010”N11ŒŽ

“Œ–k–ò‰È‘åŠw‚É‚¨‚¯‚éŽÀ–±ŽÀKŽ–‘OŠwK‚ÌŽÀŽ{‚Æ‚»‚Ì•]‰¿
”ª–Ø•ü”üCŸŽR@‘sCŠÝìK¶C’†‘º@mC—é–؏í‹`.
‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï, ç—t, 2010”N11ŒŽ

ˆã–ò•i‚̗Տ°ŒŸ¸’l–WŠQ‚ÉŠÖ‚·‚éî•ñ‚Ì‘ÌŒn‰»‚ƗՏ°î•ñ‚ÌŽûW
‚‹´–ƒ”üC—R—lj·éC“y‰®ß•vC”ª–؁@•ü”üC ŸŽR@‘sC ŠÝìK¶C’†‘º@m
‘æ49‰ñ“ú–{–òŠw‰ï“Œ–kŽx•”‘å‰ïC ŒSŽRC 2010”N10ŒŽ

å‘äŽs“à‚R•a‰@‚É‚¨‚¯‚钍ŽË—pR‹Û–òŽg—p—Ê‚Æ–òÜ‘ϐ«—¦‚Æ‚ÌŠÖ˜A
²“¡Œ\Œá
‘æ15‰ñ“ì“Œ–k‰»Šw—Ö@ƒVƒ“ƒ|ƒWƒEƒ€, å‘ä, 2010”N9ŒŽ


‰–Š˜’n‹æ‚É‚¨‚¯‚钍ŽË—pR‹Û–òŽg—pó‹µ‚Ƒϐ«‹ÛoŒ»‚Æ‚ÌŠÖ˜A’²¸•ñ
’†‘º@m
‘æ13‰ñå‰–’n‹æ‰@“àŠ´õÇŒ¤‹†‰ï, ‰–Š˜, 2010”N6ŒŽ

 

Copyright(C)2003 TOHOKU PHARMACEUTICAL UNIVERSITY All Rights Reserved

@